ARKANSAS DEPARTMENT OF HEALTH

Similar documents
Prescription Monitoring Program

1 PERSON 2 PERSON 3 PERSON 4 PERSON 5 PERSON 6 PERSON 7 PERSON 8 PERSON

This dynamic document will be reviewed and updated on a periodic basis. Each change will be recorded in the Revision History section.

Addressing Colorectal Cancer Disparities in Arkansas

Public Health In Arkansas 2009

Figure 1. Fentanyl-Related Drug Overdoses, Ohio,

Syringe Exchange: Indicators of Need & Success March 2015

PRESCRIPTION DRUG MONITORING PROGRAM ST. CHARLES COUNTY Q1 2018

Arkansas Prescription Monitoring Program

The Epidemiology of Opioid Abuse Thomas Dobbs, MD, MPH 6/30/2017

KASPER QUARTERLY THRESHOLD ANALYSIS REPORT THIRD QUARTER 2017

Arkansas Prescription Monitoring Program

1 PERSON 2 PERSON 3 PERSON 4 PERSON 5 PERSON 6 PERSON 7 PERSON 8 PERSON

PRESCRIPTION DRUG MONITORING PROGRAM

(b) A person acting in good faith who reasonably believes that another person is experiencing an opioid-related drug overdose may administer an

Shining a Light on MEDs Understanding morphine equivalent dose

Opiate Use among Ohio Medicaid Recipients

Stolen and Recovered Property: 2015

Interventions in Prescription Opioid Abuse Do (or can) Prescription Monitoring Programs Make a Difference?

Illinois Stroke Data Report

USE OF OPIODS AT HIGHER DOSES IN PERSONS WITHOUT CANCER: MORPHINE EQUIVALENT DOSE EDIT

Arkansas Prescription Monitoring Program

Stolen and Recovered Property: 2016

Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities

Executive Summary Composite Prevention Profile: Rural, Illinois

A National Perspective on the Abuse and Diversion of Prescription Drugs

Opioid Pain Contracts: A Resident Driven Quality Improvement Project

Executive Summary Composite Prevention Profile: City of Chicago, Illinois

Executive Summary Composite Prevention Profile: Urban/Suburban, Illinois (excluding Chicago Metro Area)

HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain

Governor s Commission for a Drug-Free Indiana. Commission s Purpose. Local Coordinating Councils 10/18/2013

Opioid Analgesics. Recommended starting dose for opioid-naïve patients

PACIFICSOURCE COMMUNITY SOLUTIONS AND GORGE COORDINATED CARE ORGANIZATION. Chronic Pain and Opiate Management Initiatives

NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference. Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement.

Fatal Drug Overdoses: A Growing Concern in Indiana

Opioid Management of Chronic (Non- Cancer) Pain

The Latest Prescription Trends for Controlled Prescription Drugs

CHILDHOOD HEALTH. Key findings

Tri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon. Executive Summary

Challenges in Conducting Postmarketing Abuse Investigations

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

Prescription Drug Monitoring Program Update. Rebecca R. Poston, BPharm., MHL Program Manager August 26, 2017

Ingham County Opioid Surveillance

Drug and Opioid Epidemic Report

Proposed Changes to Existing Measure for HEDIS : Use of Opioids at High Dosage (UOD)

Diversion, misuse and trafficking of methadone and buprenorphine

Opioid Deaths Quadruple Since 1999

CEREBROVASCULAR DISEASES (STROKE) MORTALITY

Key points. Background

20/0.8mg, 30/1.2mg, Films 90 MME/day Belbuca (buprenorphine) 75mcg, 150mcg, 300mcg, 450mcg 60 units per 90 days

CDC s Efforts to End the Opioid Epidemic

Indicators of Health Status in Alabama DIABETES MORTALITY. Jointly produced to assist those seeking to improve health care in rural Alabama

New Guidelines for Prescribing Opioids

Indicators of Health Status in Alabama CANCER MORTALITY. Jointly produced to assist those seeking to improve health care in rural Alabama

Arkansas Department of Health

Michael M. Miller, MD, FASAM, FAPA

Medicare Advantage Outreach and Education Bulletin

E. Omohundro, PhD, 3/15/2017 Office of Research 2

Abuse, Misuse, and Diversion of Prescription Opioids: Evaluating the Problem and Proposed Solutions

3/14/18. Why Would We Give Needles to People Who Inject Drugs? 0-30 days = 60% more Kentuckian is diagnosed with. >365 days = 17% days = 10%

Bureau of Narcotic Enforcement Update. Recent Changes to New York State s Controlled Substance Act

RADARS System International Pre-Symposium 11 May Global Insights in Prescription Drug Misuse

Key points. o Potential for nonmedical use, abuse, and diversion of new products

HHS Priorities and Actions to Support Treatment for Those with Opioid Use Disorder

Executive Summary Composite Prevention Profile: Suburban Chicago Metro Area, Illinois

Geographic variations in prescription opioid dispensations and deaths among women and men in British Columbia, Canada

Prescription Opioid Dependence and Addiction: Experience in the United States

RD INSTRUCTION 1980-D, EXHIBIT C PAGE 1 GUARANTEED HOUSING PROGRAM INCOME LIMITS

Understanding the Opioid Crisis: What s at the Heart of the Matter?

Opioid Step Policy. Description. Section: Prescription Drugs Effective Date: April 1, 2018

Comparison of 3-Year Average and ILI Rates Statewide

Diversion, Misuse and Trafficking of Methadone and Buprenorphine in the US and Europ

Allergic to hydrocodone can i take tramadol

New Mexico Prescription Monitoring Program Data Report

Medicaid and the Opioid Crisis

Opioids: Use, Abuse and Cause of Death. Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory

Policy and Political Dynamics of the Opioid Addiction Crisis in the United States

PRESCRIBING GUIDELINES

Montgomery County Poisoning Death Review, 2016: Quarter I Updated June 20, 2016

Oregon s PDMP: An epidemiological assist tool

SCG1 Evaluation of High Risk Pain Medications for MME

Mark Hurst, M.D., Medical Director

Embeda. Embeda (morphine sulfate and naltrexone hydrochloride) Description

Demerol (meperidine oral tablet, oral solution), Meperitab (oral tablet)

CLINICAL QUALITY MEASURES Public Reports. as of 09/30/2013

9/5/2011. Outline. 1. Past and Current Trends re: RX Abuse 2. Diversion Methods 3. Regulatory Reporting Requirements 4. Q/A

Idaho DUR Board Meeting Minutes. Committee Member Present: David Agler, M.D., Dawn Berheim, Pharm.D., Perry Brown, M.D., Matthew Hyde, Pharm.D.

Pain Management and Safe use of opioids in hospitals. Kyoung-Sil Kang, PharmD, BCPS Scott Tam, PharmD Lauve Casimir, RN, MSN

Drug Name (specify drug) Quantity Frequency Strength

Carefirst. +.V Family of health care plans

Opioid Prescription and Illicit Drug Overdoses: On the Rise

Opioid Harm Reduction

Morphine er to oxycontin conversion

DEA: Combating the Supply

15 mg morphine 10 mg hydrocodone

Targeting an Epidemic: Opioid Prescribing Patterns by County in New York State

Understanding the Opiate Epidemic

CLINICAL POLICY DEPARTMENT: Medical

Aetna s Initiative on the Opioid Epidemic

The Care Alliance for Opioid Dependence

Transcription:

Thank you for taking an interest in the Arkansas Prescription Monitoring Program (PMP). The goal of the PMP is to enhance patient care by ensuring the legitimate use of controlled substances. The following maps provide 2015 dispensing data for individual opioid pain medications in Arkansas. The data are displayed at the county level according to recipient address. Large differences in rates in different counties could indicate misuse of these drugs.

Oxycodone Dispensed Per Capita in 2015 Oxycodone is the most prescribed high-potency opioid in Arkansas. This map shows the average amount of oxycodone dispensed in Arkansas 75 counties in 2015. In Carroll, Conway, Crawford, Madison, Marion, Sharp and Perry counties, the amount of oxycodone dispensed was approximately two times higher than the state average.

Oxycodone Recipients Per 10,000 People in 2015 This map shows the average number of oxycodone recipients in each of Arkansas 75 counties. The rate per person has been multiplied by 10,000 to create whole numbers. Carroll, Grant, Lonoke, Madison, Perry, Pulaski, Saline, Sharp and Washington were the counties with the largest percentage of oxycodone users in 2015.

Hydrocodone Dispensed Per Capita in 2015 Hydrocodone is the most prescribed opioid in Arkansas. Last year in Chicot, Crawford, Garland, Greene, Montgomery, Phillips, Pike, Poinsett, Sharp and Stone counties, the equivalent of 53 65 doses of hydrocodone were dispensed per capita.

Hydrocodone Recipients Per 10,000 People in 2015 This map shows the average number of hydrocodone recipients in each of Arkansas 75 counties. The values have been multiplied by 10,000 to make them easier to read. In 2015, hydrocodone use was more prevalent in Crawford, Franklin, Garland, Greene, Jackson, Lawrence, Ouachita, Perry, Phillips, Poinsett and Sharp counties

Hydromorphone Quantity Dispensed Per Capita in 2015 Hydromorphone is the most potent drug in this series. Hydromorphone is not prescribed very often in Arkansas, but it still warrants attention due to its high potency. Calhoun, Fulton, Izard, Madison and Sharp were the counties where the most hydromorphone was dispensed in 2015.

Hydromorphone Recipients Per 10,000 People in 2015 The number of hydromorphone recipients varied widely in 2015. The counties that are shown in red on this map had more than twice as many hydromorphone recipients than average.

Methadone Quantity Dispensed Per Capita in 2015 Methadone is used to treat opioid addiction and is used to treat pain as well. This map shows the average amount of methadone dispensed in 2015. These numbers do not include methadone dispensed in drug treatment centers due to federal restrictions.

Methadone Recipients Per 10,000 People in 2015 Five counties stand out where methadone use was more common. Calhoun, Lawrence, Poinsett, Randolph and Scott counties had the largest percentage of methadone recipients in 2015.

Oxymorphone Quantity Dispensed Per Capita in 2015 Oxymorphone is a highpotency prescription opioid that has been associated with outbreaks of HIV and Hepatitis C due to intravenous abuse. In 2015, the average amount of oxymorphone dispensed was highest in Cleburne, Crawford, Logan and Sebastian counties.

Oxymorphone Recipients Per 10,000 People in 2015 Five counties in western Arkansas had the highest percentage of oxymorphone recipients. Crawford, Franklin, Logan, Sebastian and Scott counties had three times more oxymorphone recipients than average.

Tramadol Quantity Dispensed Per Capita in 2015 Tramadol is a lower potency opioid. Fulton, Grant, Izard, Logan, Madison, Poinsett and Stone were the counties where the most tramadol was dispensed in 2015.

Tramadol Recipients Per 10,000 People in 2015 Four counties in Arkansas had large percentages of tramadol recipients: Cross, Dallas, Monroe and Poinsett.

Morphine Quantity Dispensed Per Capita in 2015 The counties shown in red on this map had the highest amounts of morphine dispensed on average in 2015.

Morphine Recipients Per 10,000 People in 2015 The counties shown in red on this map had the largest percent of morphine recipients.

Buprenorphine Quantity Dispensed Per Person in 2015 Buprenorphine is used to treat pain and to treat opioid addiction. Unlike methadone, buprenorphine is often dispensed from retail pharmacies. Garland county had the highest rate of buprenorphine dispensed in 2015.

Buprenorphine Recipients Per 10,000 People in 2015 The percentage of buprenorphine recipients varies widely from county to county. In 2015, Baxter, Scott, Garland, Saline and Union county had the largest percentage of buprenorphine recipients.